Article

A new approach towards developing a smart and multifunctional peptide-based drug delivery system for selective targeting and treatment of invasive/metastatic breast cancer.

Walhan Alshaer1, Hamdi Nsairat2, Malek Zihlif3★★ Corresponding author

  1. 1Cell Therapy Center, the University of Jordan, Amman 11942, Jordan.
  2. 2Pharmacological and Diagnostic Research Center, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman 19328, Jordan.
  3. 3Department of Pharmacology, Faculty of Medicine, The University of Jordan, Amman, Jordan.

CORRESPONDENCE

Malek Zihlif

Department of Pharmacology, Faculty of Medicine, The University of Jordan, Amman, Jordan.

m.zihlif@ju.edu.jo

Received: 20-03-2025; Accepted: 01-05-2025.

Volume 23, Issue 4 · pp. 3172 · PUBLISHED Oct-Dec 2025 · DOI: 10.18549/PharmPract.2025.4.3172

View on PP original site ↗

ABSTRACT

Cancer remains one of the leading causes of morbidity and mortality worldwide. Breast cancer is the most frequently diagnosed cancer and causes cancer-related deaths in women. In cancer, targeted drugs are often divided into two strategies: “passive targeting” and “active targeting”. Passive targeting suffers from low selectivity and poor retention in tumors. Such limitations lead to the development of an active targeting strategy. Active targeting describes the specific interaction between drugs or drug carriers and target cells, which usually occurs through receptor-ligand interactions. Here, we propose to develop a peptide-based drug conjugate as a novel targeted drug delivery system that enhances selectivity, localization, and activity of antitumor therapeutics on metastatic and invasive breast cancer cells by using endoxefin (END) as a targeting ligand for estrogen receptor, Metalloproteinase peptide-substrate (MMP2) for trigger release of drug, and doxorubicin (DOX) as an antitumor therapeutic.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Alshaer, W., Nsairat, H., & Zihlif, M. (2025). A new approach towards developing a smart and multifunctional peptide-based drug delivery system for selective targeting and treatment of invasive/metastatic breast cancer.. Pharmacy Practice, 23(4), 3172. https://doi.org/10.18549/PharmPract.2025.4.3172